Fri. Dec 27th, 2024

Tirzepatide cuts diabetes risk by 94% in SURMOUNT-1 trial – Drug Discovery & Development

Byadmin

Aug 21, 2024

By admin

Related Post

CORXEL Acquires Worldwide (excluding Greater China) Rights to an Oral Small Molecule GLP-1 RA for the Treatment of Obesity and Diabetes – South Florida Hospital News

Dec 27, 2024 admin

Metformin improves depressive symptoms in type 2 diabetes patients over 24 weeks, study finds – PsyPost

Dec 27, 2024 admin

Addressing “Metabolic Syndrome”: Key to tackling type-2 diabetes in India – The Economic Times

Dec 27, 2024 admin

Leave a Reply Cancel reply

You missed

CORXEL Acquires Worldwide (excluding Greater China) Rights to an Oral Small Molecule GLP-1 RA for the Treatment of Obesity and Diabetes – South Florida Hospital News

Dec 27, 2024 admin

Metformin improves depressive symptoms in type 2 diabetes patients over 24 weeks, study finds – PsyPost

Dec 27, 2024 admin

Addressing “Metabolic Syndrome”: Key to tackling type-2 diabetes in India – The Economic Times

Dec 27, 2024 admin

Sir David Attenborough ditches common food linked to diabetes – Kent Live

Dec 27, 2024 admin